The efficacy and safety of vascular endothelial growth factor receptor (VEGFR ) inhibitors for recurrent ovarian cancer: a systematic review and meta-analysis | Zendy

AI Assistant Blog Pricing

The efficacy and safety of vascular endothelial growth factor receptor (VEGFR ) inhibitors for recurrent ovarian cancer: a systematic review and meta-analysis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.